Co-founder and CEO Dave Suchon told BNN Bloomberg the company intends to develop and manufacture domestically: Were going to be making it here in Canada Weve done our research and development here in Canada as well. The company says, the potential is phenomenal. Novo Nordisks semaglutide products Ozempic and Wegovy have been blockbuster sensations as millions of people have sought them to treat type 2 diabetes, weight loss, obesity and other health conditions
Using a medication diary, smartphone reminder, or marking a calendar can help track doses
Shop ALL high purity Peptide Nasal Sprays for sale from our online store
Well talk about the promise of these therapies, the risks and regulatory challenges surrounding non-FDA approved compounded versions, and what the next phase could mean for patients, providers, policymakers and industry
This lack of standardization introduces chaos
How a GLP-3 Triple Agonist Works A triple agonist attempts to coordinate three receptor systems in one molecule